Dental sedation study pulled before it began

NCT ID NCT06793358

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if a combination of remimazolam and fentanyl could safely sedate patients during dental extractions lasting 30 minutes or less. It planned to enroll healthy adults needing tooth removal. However, the trial was withdrawn before any participants were enrolled, so no data was collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

remimazolam and fentanyl

What this could lead to

If it had worked, this could have pointed toward a safe, fast-acting sedation option for short dental procedures.

What could go wrong

The study was withdrawn before any participants were enrolled, so no results are available. The combination had not been tested in dental extractions before.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENTAL EXTRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Indiana University School of Dentistry (IUSD)

    Indianapolis, Indiana, 46202, United States